SOLV

Solventum Corp SOLV

NYSELarge CapHealthcare

13F Pro quality score

Rank #1,232 of 2,925TOP 50%

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$2.21B

Quarter to Jun 30

Net income

$92.00M

Quarter to Jun 30

Free cash flow

$144.00M

Quarter to Jun 30

Operating margin

8.2%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$9.83B total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SOLV

Earnings Per Share

13fpro.ai/company/SOLV

Loading ratio trend…

SOLV key financials by period

Reported revenue, net income and operating margin by fiscal year, from Solventum Corp's annual filings on SEC EDGAR.

Solventum Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$8.3B$1.6B26.2%
FY 2024$8.3B$479.0M12.6%
FY 2023$8.2B$1.3B20.6%
FY 2022$8.1B$1.3B20.8%
Source: SOLV filings on SEC EDGAR →

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

SOLV insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in SOLV

6 transactions in SOLV reported by 6 members of Congress under the STOCK Act, most recent trade Dec 31, 2025. Reported transactions, not recommendations.

All Congress stock trades →

About Solventum Corp (SOLV): stock profile, AI score and financials

Solventum Corp (SOLV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SOLV at 55.5/100 on a composite quality score built from its SEC filings, placing it at rank #1,232 of 2,925 stocks — the top half of the AI-ranked universe. SOLV scores in the top quartile across balance sheet strength (84.9), revenue scale (84.3), profitability (81.5). Areas of concern include free cash flow (24.4) and revenue growth (27.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Solventum Corp reports quarterly revenue of $2.2B, net income of $92.0M, an operating margin of 8.2%. Top institutional holders of SOLV by reported 13-F value include Independent Franchise Partners LLP, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. SOLV trades on the NYSE exchange and files with the SEC under CIK 1964738. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SOLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Solventum Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1964738 →